Cronos Group Inc. (CRON) Financial Statements (2023 and earlier)
Company Profile
Business Address |
111 PETER STREET TORONTO, ON M5V 2H1 |
State of Incorp. | ON |
Fiscal Year End | December 31 |
Industry (SIC) | 2833 - Medicinal Chemicals and Botanical Products (benchmarking) |
More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in millions)Annual | Quarterly
9/30/2022 Q3 | 6/30/2022 Q2 | 3/31/2022 Q1 | 12/31/2021 Q4 | 9/30/2021 Q3 | 6/30/2021 Q2 | |||
---|---|---|---|---|---|---|---|---|
ASSETS | ||||||||
Current Assets | ||||||||
Cash, cash equivalents, and short-term investments | 889 | 945 | 981 | 1,005 | 1,040 | 1,097 | ||
Cash and cash equivalents | 633 | 790 | 862 | 887 | 843 | 895 | ||
Short-term investments | 255 | 155 | 120 | 118 | 197 | 202 | ||
Receivables | 32 | 29 | 35 | 34 | 22 | 19 | ||
Inventory, net of allowances, customer advances and progress billings | 34 | 40 | 37 | 33 | 32 | 36 | ||
Inventory | 34 | 40 | 37 | 33 | 32 | 36 | ||
Assets held-for-sale, not part of disposal group | 1 | |||||||
Other undisclosed current assets | 9 | 12 | 10 | 8 | 10 | 10 | ||
Total current assets: | 963 | 1,026 | 1,063 | 1,080 | 1,104 | 1,162 | ||
Noncurrent Assets | ||||||||
Operating lease, right-of-use asset | 5 | 6 | 6 | 9 | 9 | 7 | ||
Property, plant and equipment | 61 | 66 | 72 | 74 | 189 | 193 | ||
Long-term investments and receivables | 186 | 209 | 210 | 216 | 211 | 226 | ||
Long-term investments | 114 | 130 | 129 | 135 | 129 | 132 | ||
Accounts and financing receivable, after allowance for credit loss | 72 | 78 | 82 | 81 | 81 | 94 | ||
Intangible assets, net (including goodwill) | 22 | 25 | 19 | 19 | 22 | 15 | ||
Goodwill | 1 | 1 | 1 | 1 | 1 | 1 | ||
Intangible assets, net (excluding goodwill) | 21 | 24 | 18 | 18 | 20 | 14 | ||
Other noncurrent assets | 0 | 0 | 0 | 0 | 1 | |||
Total noncurrent assets: | 274 | 306 | 308 | 318 | 431 | 440 | ||
TOTAL ASSETS: | 1,237 | 1,332 | 1,371 | 1,398 | 1,535 | 1,602 | ||
LIABILITIES AND EQUITY | ||||||||
Liabilities | ||||||||
Current Liabilities | ||||||||
Accounts payable and accrued liabilities | 36 | 36 | 34 | 37 | ||||
Accounts payable | 10 | 12 | 11 | 11 | ||||
Accrued liabilities | 26 | 24 | 23 | 26 | ||||
Taxes payable | 0 | |||||||
Derivative instruments and hedges, liabilities | 0 | 1 | 4 | 14 | 35 | 170 | ||
Due to related parties | 0 | |||||||
Other undisclosed current liabilities | 2 | 2 | 2 | 3 | 35 | 31 | ||
Total current liabilities: | 38 | 39 | 40 | 54 | 70 | 201 | ||
Noncurrent Liabilities | ||||||||
Long-term debt and lease obligation | 5 | 7 | 7 | 7 | 7 | 6 | ||
Operating lease, liability | 5 | 7 | 7 | 7 | 7 | 6 | ||
Liabilities, other than long-term debt | 3 | 1 | 2 | 2 | 2 | 2 | ||
Deferred income tax liabilities | 2 | 0 | 0 | 0 | ||||
Due to related parties | 1 | 1 | 2 | 2 | 2 | 2 | ||
Total noncurrent liabilities: | 8 | 8 | 9 | 9 | 9 | 8 | ||
Total liabilities: | 46 | 47 | 50 | 63 | 79 | 209 | ||
Stockholders' equity | ||||||||
Stockholders' equity attributable to parent | 1,194 | 1,288 | 1,325 | 1,337 | 1,459 | 1,397 | ||
Common stock | 605 | 605 | 596 | 595 | 587 | 573 | ||
Additional paid in capital | 38 | 35 | 35 | 32 | 30 | 32 | ||
Accumulated other comprehensive income (loss) | (19) | 42 | 66 | 50 | 49 | 72 | ||
Retained earnings | 570 | 607 | 627 | 659 | 793 | 720 | ||
Stockholders' equity attributable to noncontrolling interest | (3) | (3) | (3) | (3) | (3) | (3) | ||
Total stockholders' equity: | 1,191 | 1,285 | 1,321 | 1,334 | 1,456 | 1,394 | ||
TOTAL LIABILITIES AND EQUITY: | 1,237 | 1,332 | 1,371 | 1,398 | 1,535 | 1,602 |
Income Statement (P&L) ($ in millions) Annual | Quarterly
9/30/2022 Q3 | 6/30/2022 Q2 | 3/31/2022 Q1 | 12/31/2021 Q4 | 9/30/2021 Q3 | 6/30/2021 Q2 | ||
---|---|---|---|---|---|---|---|
Revenues | 21 | 23 | 25 | 26 | 20 | 16 | |
Cost of revenue (Cost of Goods and Services Sold) | (6) | (5) | (4) | (6) | (4) | (15) | |
Other undisclosed gross profit | (14) | (13) | (14) | (18) | (17) | (16) | |
Gross profit: | 1 | 4 | 7 | 2 | (1) | (16) | |
Operating expenses | (32) | (32) | (43) | (165) | (56) | (281) | |
Operating loss: | (31) | (28) | (36) | (163) | (56) | (296) | |
Nonoperating income (expense) | (4) | 7 | 4 | 28 | 134 | 118 | |
Investment income, nonoperating | 0 | 3 | 10 | 22 | 135 | 118 | |
Foreign currency transaction gain (loss), before tax | 2 | (3) | (2) | ||||
Other nonoperating income (expense) | (1) | 0 | 0 | (0) | 0 | 1 | |
Interest and debt expense | (0) | (0) | (0) | ||||
Income (loss) from continuing operations before equity method investments, income taxes: | (35) | (21) | (32) | (134) | 77 | (179) | |
Loss from equity method investments | (6) | ||||||
Other undisclosed income from continuing operations before income taxes | 6 | 0 | |||||
Income (loss) from continuing operations before income taxes: | (35) | (21) | (32) | (134) | 77 | (179) | |
Income tax expense (benefit) | (2) | 0 | (0) | 0 | 0 | ||
Other undisclosed income from continuing operations | 0 | ||||||
Income (loss) from continuing operations: | (37) | (20) | (33) | (134) | 78 | (179) | |
Income (loss) from discontinued operations | 0 | (1) | |||||
Net income (loss): | (37) | (20) | (33) | (134) | 78 | (179) | |
Net income (loss) attributable to noncontrolling interest | (0) | 0 | 0 | 0 | 0 | 0 | |
Net income (loss) available to common stockholders, diluted: | (37) | (20) | (33) | (134) | 78 | (179) |
Comprehensive Income ($ in millions)Annual | Quarterly
9/30/2022 Q3 | 6/30/2022 Q2 | 3/31/2022 Q1 | 12/31/2021 Q4 | 9/30/2021 Q3 | 6/30/2021 Q2 | ||
---|---|---|---|---|---|---|---|
Net income (loss): | (37) | (20) | (33) | (134) | 78 | (179) | |
Other comprehensive income (loss) | 1 | (23) | 13 | ||||
Other undisclosed comprehensive income (loss) | (61) | (24) | 16 | ||||
Comprehensive income (loss): | (97) | (44) | (17) | (133) | 55 | (166) | |
Comprehensive income (loss), net of tax, attributable to noncontrolling interest | (0) | (0) | 0 | (0) | 0 | 0 | |
Comprehensive income (loss), net of tax, attributable to parent: | (98) | (45) | (16) | (133) | 55 | (165) |
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.